Is Genovate Biotechnology Co stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Genovate Biotechnology Co pays dividends. Last time was Wednesday 25th of September 2024 where the investors holding the stock on Wednesday 21st of August 2024 were paid TWD0.15 per share. Over the last 12 times between 2013 and 2024, Genovate Biotechnology Co has paid TWD4.6224 with an average of TWD0.39 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Genovate Biotechnology Co 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD24.92, you would have made a loss of TWD-2.97 per share or -11.92%
Yes, the average daily trading liquidity for Genovate Biotechnology Co is TWD101 516 thousand. You should therefore be able to get in and out of your positions relatively fast.
Genovate Biotechnology Co has no real debt, which is good in periods of high inflation. The company has a very low net profit margin of 3.10%, which is challenging.
We have calculated the inflation risk for Genovate Biotechnology Co to be low [0.5 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.